Skip to main content
Premium Trial:

Request an Annual Quote

NeoProteomics Licenses Technology from Case Western Reserve University

By a GenomeWeb Staff Reporter

NEW YORK (GenomeWeb News) – Biomarker development and software firm NeoProteomics announced late on Friday that it has reached an exclusive option agreement to license technologies from Case Western Reserve University.

Under the agreement, NeoProteomics will have access to tools and biomarkers that will expand its portfolio in personalized medicine, according to a statement from the university. "The deal has potential to enhance various forms of treatment of cancer, diabetes, and inflammatory diseases," it added.

Founded in 2006 and based in Cleveland, NeoProteomics identifies and validates protein biomarkers "and seeks to spearhead the development of unique and improved analysis tools," Case Western Reserve said.

Financial and other terms of the deal were not disclosed.

NeoProteomics was co-founded by John Schenkel and Mark Chance. Schenkel is currently president and CEO of NeoProteomics.

Chance, who now serves as the company's chief scientific officer, is also director of the Case Center for Proteomics and Bioinformatics and is a professor and interim chair in the department of genetics at the university's School of Medicine.

NeoProteomics is distributing software licensed from Case Western Reserve called ProtMapMS, which automates mass spectrometry workflows. The university said the software has been licensed to major drug manufacturers and a number of prestigious research universities.

The company will offer other bioinformatics software, currently under development, from the Case Western Reserve for the integration of high-throughput genomics and proteomics data in clinical research.

The Scan

Harvard Team Report One-Time Base Editing Treatment for Motor Neuron Disease in Mice

A base-editing approach restored SMN levels and improved motor function in a mouse model of spinal muscular atrophy, a new Science paper reports.

International Team Examines History of North American Horses

Genetic and other analyses presented in Science find that horses spread to the northern Rockies and Great Plains by the first half of the 17th century.

New Study Examines Genetic Dominance Within UK Biobank

Researchers analyze instances of genetic dominance within UK Biobank data, as they report in Science.

Cell Signaling Pathway Identified as Metastasis Suppressor

A new study in Nature homes in on the STING pathway as a suppressor of metastasis in a mouse model of lung cancer.